Edgewise Therapeutics Inc (EWTX)
12.19 x 11 12.90 x 1
Post-market by (Cboe BZX)
11.51 -2.07 (-15.24%) 04/04/25 [NASDAQ]
12.19 x 11 12.90 x 1
Post-market 12.18 +0.67 (+5.82%) 19:34 ET
for Fri, Apr 4th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -133,813 | -100,163 | -67,640 | -42,813 | -17,123 |
| Depreciation Amortization | -10,255 | -7,785 | -5 | 272 | 185 |
| Accounts payable and accrued liabilities | 1,737 | -92 | 47 | 2,654 | 521 |
| Other Working Capital | 10,328 | -1,560 | 4,086 | 4,630 | 1,950 |
| Other Operating Activity | 22,975 | 17,652 | 10,877 | 1,750 | -167 |
| Operating Cash Flow | $-109,028 | $-91,948 | $-52,635 | $-33,507 | $-14,634 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,312 | -5,745 | -5,546 | -668 | -203 |
| Purchase Of Investment | -477,055 | -255,866 | -95,605 | -245,003 | -24,178 |
| Sale Of Investment | 293,711 | 364,497 | 30,574 | 3,444 | N/A |
| Investing Cash Flow | $-184,656 | $102,886 | $-70,577 | $-242,227 | $-24,381 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 249,515 | 53,331 | 129,890 | 360 | 202 |
| Other Financing Activity | -262 | -165 | -251 | 186,024 | 120,076 |
| Financing Cash Flow | $249,253 | $53,166 | $129,639 | $186,384 | $120,278 |
| Beginning Cash Position | 86,097 | 21,993 | 15,566 | 104,916 | 23,653 |
| End Cash Position | 41,666 | 86,097 | 21,993 | 15,566 | 104,916 |
| Net Cash Flow | $-44,431 | $64,104 | $6,427 | $-89,350 | $81,263 |
| Free Cash Flow | |||||
| Operating Cash Flow | -109,028 | -91,948 | -52,635 | -33,507 | -14,634 |
| Capital Expenditure | -1,312 | -5,745 | -5,546 | -668 | -203 |
| Free Cash Flow | -110,340 | -97,693 | -58,181 | -34,175 | -14,837 |